Many people have experienced the lightheaded or dizzy feeling after standing up too quickly. For most people, this is normal and the body adjusts within about a minute. However, in some people, the body struggles to adjust to standing up from a sitting or a lying position and the dizziness can last for several minutes. This condition is called Orthostatic Hypotension (OH). OH is caused by a sudden fall in blood pressure and is due to the body being unable to maintain blood pressure at nearly constant levels when moving, especially standing or rising quickly. Neurogenic Orthostatic Hypotension (nOH) is a related condition with similar symptoms, but is caused by Multiple System Atrophy (MSA), Parkinson’s disease (PD), or pure autonomic failure
The prevalence of OH increases with age and is reportedly present in 5%-30% of people over the age of 65. In patients with MSA, PD or PAF the prevalence of nOH is much higher and can occur in up to 85% of symptomatic patients. In elderly people, this condition can be very dangerous, as it can lead to weakness or dizziness, which could cause fainting or falls. Symptoms could easily be dismissed because they they can pass quickly, but the underlying problem still exists and should not be ignored.
While treatments are available now, researchers are always looking to improve existing methods or find new solutions which may have better performance and/or fewer side effects. These investigational treatments are studied through a process called clinical research or clinical trials. A clinical trial is conducted by medical professionals and can include several visits, during which participants may receive an investigational treatment, or placebo (a study drug look-alike that has no active medicine), depending on the study.
CNS, a leading clinical research site in southern California, is seeking participants for a Neurogenic Orthostatic Hypotension clinical trial now. Individuals who suffer from nOH due to, Multiple System Atrophy, Parkinson’s disease or pure autonomic failure and are at least 40 years old, may be eligible. Qualified participants may receive investigational medication and medical care at no cost and may be reimbursed for time and travel.
To learn more about nOH and clinical research, contact CNS today by calling 844-213-3335 or online at www.cnstrial.com. Participants are needed now.